Aimee J. Foreman

4.7k citations

33 papers · 3.3k indexed · 3 hit papers · h-index 17

Pulmonary and Respiratory Medicine top 0.5%
Cardiology and Cardiovascular Medicine top 1%
Genetics top 2%
Epidemiology top 10%
Surgery top 10%

Co-authors: Michael D. McGoon Dave P. Miller Raymond L. Benza Adaani Frost Mardi Gomberg‐Maitland Robert P. Frantz C. Gregory Elliott David B. Badesch
Topics: Pulmonary Hypertension Research and Treatments (16 papers)Cardiovascular Issues in Pregnancy (6 papers)Chronic Myeloid Leukemia Treatments (5 papers)
Cited by: Pulmonary and Respiratory Medicine Cardiology and Cardiovascular Medicine Genetics
Journals: Circulation Journal of Clinical Oncology Blood
Partner nations: United States Sweden Italy

In The Last Decade

Aimee J. Foreman

33 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Predicting Survival in Pulmonary Arterial Hypertension

2010 1.1k citations Raymond L. Benza, Dave P. Miller et al. Circulation profile →
Predicting Survival in Patients With Pulmonary Arterial Hypertension

2019 390 citations Raymond L. Benza, Mardi Gomberg‐Maitland et al. CHEST Journal profile →
The REVEAL Registry Risk Score Calculator in Patients Newly Diagnosed With Pulmonary Arterial Hypertension

2011 389 citations Raymond L. Benza, Mardi Gomberg‐Maitland et al. CHEST Journal profile →

Peers

Countries citing papers authored by Aimee J. Foreman

Since Specialization

Citations

This map shows the geographic impact of Aimee J. Foreman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aimee J. Foreman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aimee J. Foreman more than expected).

Fields of papers citing papers by Aimee J. Foreman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aimee J. Foreman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aimee J. Foreman. The network helps show where Aimee J. Foreman may publish in the future.

Co-authorship network of co-authors of Aimee J. Foreman

This figure shows the co-authorship network connecting the top 25 collaborators of Aimee J. Foreman. A scholar is included among the top collaborators of Aimee J. Foreman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aimee J. Foreman. Aimee J. Foreman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Using Oncotype DX breast recurrence score® assay to define the role of neoadjuvant endocrine therapy in early-stage hormone receptor-positive breast cancer 2023 ·Breast Cancer Research and Treatment ·Caitlin Taylor,Jane Meisel,Aimee J. Foreman,Christy Russell,Dipankar Bandyopadhyay,(unknown),(unknown),Amelia Zelnak,Harry D. Bear,Ruth O’Regan	5
2	The 17-Gene Genomic Prostate Score Assay Is Prognostic for Biochemical Failure in Men With Localized Prostate Cancer After Radiation Therapy at a Community Cancer Center 2023 ·Advances in Radiation Oncology ·Daniel Canter,(unknown),(unknown),Aimee J. Foreman,(unknown),(unknown),David K. Edwards,(unknown)	4
3	Predicting Survival in Patients With Pulmonary Arterial Hypertensionbreakdown → 2019 ·CHEST Journal ·Raymond L. Benza,Mardi Gomberg‐Maitland,C. Gregory Elliott,Harrison W. Farber,Aimee J. Foreman,Adaani Frost,Michael D. McGoon,David J. Pasta,Mona Selej,Charles D. Burger,Robert P. Frantz	390
4	More than a decade follow-up in patients with severe or difficult-to-treat asthma: The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) II 2017 ·Journal of Allergy and Clinical Immunology ·Bradley E. Chipps,Tmirah Haselkorn,(unknown),Benjamin Ortiz,Eugene R. Bleecker,Farid Kianifard,Aimee J. Foreman,Stanley J. Szefler,Robert S. Zeiger	56
5	Tyrosine Kinase Inhibitor (TKI) Switching Patterns during the First 12 Months in Simplicity, an Observational Study of Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Patients (Pts) in Routine Clinical Practice 2016 ·Blood ·Stuart L. Goldberg,Mauricette Michallet,Rüdiger Hehlmann,Teresa Zyczynski,Aimee J. Foreman,Brian Calimlim,Ron Paquette,Bengt Simonsson,(unknown),Jörge E. Cortes,(unknown),(unknown),Michael J. Mauro	2
6	Prognostic implications of serial risk score assessments in patients with pulmonary arterial hypertension: A Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) analysis 2014 ·The Journal of Heart and Lung Transplantation ·Raymond L. Benza,Dave P. Miller,Aimee J. Foreman,Adaani Frost,David B. Badesch,Wade W. Benton,Michael D. McGoon	103
7	Four- and Seven-Year Outcomes of Patients With Congenital Heart Disease–Associated Pulmonary Arterial Hypertension (from the REVEAL Registry) 2013 ·The American Journal of Cardiology ·Robyn J. Barst,D. Dunbar Ivy,Aimee J. Foreman,Michael D. McGoon,Erika B. Rosenzweig	86
8	Baseline Characteristics Of Patients With Chronic Myeloid Leukemia In a Prospective Observational Study (SIMPLICITY) 2013 ·Blood ·Jörge E. Cortes,Rüdiger Hehlmann,Carlo Gambacorti‐Passerini,Stuart L. Goldberg,H. Jean Khoury,Michael J. Mauro,Mauricette Michallet,Ron Paquette,Bengt Simonsson,Aimee J. Foreman,Hesham Mohamed,Teresa Zyczynski,Ishan Hirji,Catherine Davis	4
9	Risk assessment in pulmonary hypertension associated with heart failure and preserved ejection fraction 2012 ·The Journal of Heart and Lung Transplantation ·Richa Agarwal,Sanjiv J. Shah,Aimee J. Foreman,(unknown),Sonja Bartolome,Zeenat Safdar,(unknown),Allen S. Anderson,Mardi Gomberg‐Maitland	37
10	Survival in Childhood Pulmonary Arterial Hypertension 2011 ·Circulation ·Robyn J. Barst,Michael D. McGoon,C. Gregory Elliott,Aimee J. Foreman,Dave P. Miller,D. Dunbar Ivy	262
11	The REVEAL Registry Risk Score Calculator in Patients Newly Diagnosed With Pulmonary Arterial Hypertensionbreakdown → 2011 ·CHEST Journal ·Raymond L. Benza,Mardi Gomberg‐Maitland,Dave P. Miller,Adaani Frost,Robert P. Frantz,Aimee J. Foreman,David B. Badesch,Michael D. McGoon	389
12	Treadmill testing improves survival prediction models in pulmonary arterial hypertension 2011 ·American Heart Journal ·Chih‐Hsin Hsu,(unknown),Aimee J. Foreman,Richa Agarwal,(unknown),Robert P. Frantz,Mardi Gomberg‐Maitland	12
13	Comparison of Body Habitus in Patients With Pulmonary Arterial Hypertension Enrolled in the Registry to Evaluate Early and Long-term PAH Disease Management With Normative Values From the National Health and Nutrition Examination Survey 2011 ·Mayo Clinic Proceedings ·Charles D. Burger,Aimee J. Foreman,Dave P. Miller,Robert E. Safford,Michael D. McGoon,David B. Badesch	36
14	Predicting Survival in Pulmonary Arterial Hypertensionbreakdown → 2010 ·Circulation ·Raymond L. Benza,Dave P. Miller,Mardi Gomberg‐Maitland,Robert P. Frantz,Aimee J. Foreman,Christopher S. Coffey,Adaani Frost,Robyn J. Barst,David B. Badesch,C. Gregory Elliott,Theodore G. Liou,Michael D. McGoon	1139
15	Prognostic Value Of Percent Predicted Six Minute Walk Test Distance In Idiopathic Pulmonary Arterial Hypertension Patients: An Analysis Of The REVEAL Registry 2010 ·Stephen C. Mathai,Raymond L. Benza,Aimee J. Foreman,Paul M. Hassoun	2
16	Trends in Medical Care Expenditures of US Adults with Arthritis and Other Rheumatic Conditions 1997 to 2005 2009 ·The Journal of Rheumatology ·Miriam G. Cisternas,Louise B. Murphy,Edward H. Yelin,Aimee J. Foreman,David J. Pasta,Charles G. Helmick	40
17	Hyponatremia and hospital outcomes among patients with pneumonia: a retrospective cohort study 2008 ·BMC Pulmonary Medicine ·Marya D. Zilberberg,Alex Exuzides,James Spalding,Aimee J. Foreman,Alison Graves Jones,Chris Colby,Andrew F. Shorr	101
18	Epidemiology, clinical and economic outcomes of admission hyponatremia among hospitalized patients 2008 ·Current Medical Research and Opinion ·Marya D. Zilberberg,Alex Exuzides,James Spalding,Aimee J. Foreman,Alison Graves Jones,Chris Colby,Andrew F. Shorr	206
19	Medical care expenditures and earnings losses among persons with arthritis and other rheumatic conditions in 2003, and comparisons with 1997 2007 ·Arthritis & Rheumatism ·Edward H. Yelin,Louise B. Murphy,Miriam G. Cisternas,Aimee J. Foreman,David J. Pasta,Charles G. Helmick	176
20	Vaginitis 1990 ·Postgraduate Medicine ·Aimee J. Foreman,Catherine Smith	2

About Aimee J. Foreman

Aimee J. Foreman is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Hematology, having authored 33 papers that have together received 3.3k indexed citations. Recurring topics across this work include Pulmonary Hypertension Research and Treatments (16 papers), Cardiovascular Issues in Pregnancy (6 papers) and Chronic Myeloid Leukemia Treatments (5 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (2.8k citations), Cardiology and Cardiovascular Medicine (1.8k citations) and Genetics (532 citations). Aimee J. Foreman has collaborated with scholars based in United States, Sweden and Italy. Frequent co-authors include Michael D. McGoon, Dave P. Miller, Raymond L. Benza, Adaani Frost, Mardi Gomberg‐Maitland, Robert P. Frantz, C. Gregory Elliott, David B. Badesch, Robyn J. Barst and Christopher S. Coffey. Their work appears in journals such as Circulation, Journal of Clinical Oncology and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact